POSSIBILITIES OF ENHANCED EXTERNAL COUNTERPULSATION USING IN CLINICAL PRACTICE
https://doi.org/10.20996/1819-6446-2017-13-2-238-247
Abstract
Possibilities and prospects for the clinical use of enhanced external counterpulsation (EECP), which has long established itself throughout the world, are discussed in the article. Historical background, as well as the development stages of EECP for the treatment of patients with coronary heart disease (CHD) and chronic heart failure (CHF) are considered. The mechanism of action of the EECP and the main hemodynamic, neurohumoral and tissue effects that justify its use are presented. The effect of EECP on endothelial function and coronary reserve, disorders of which occurs in the majority of cardiovascular diseases, is considered separately. Treatment of patients with CHD, including complicated by CHF, are the most studied indications for EECP using in medical practice. The evidence base for treatment of patients with these disorders by EECP is presented in the article. Prospects for the EECP application in other areas of medicine are also presented.
About the Authors
Z. A. Mamieva
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Zarina A. Mamieva - 6th Year Student, Medical Faculty
Trubetskaya ul. 8,Moscow, 119991
A. S. Lishuta
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Alexey S. Lishuta - MD, PhD, Associate Professor, Chair of Hospital Therapy №1
Trubetskaya ul. 8,Moscow, 119991
Yu. N. Belenkov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Yuri N. Belenkov - MD, PhD, Professor, Academician of the Russian Academy of Sciences, Head of Chair of Hospital Therapy №1
Trubetskaya ul. 8,Moscow, 119991
E. V. Privalova
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Elena V. Privalova - MD, PhD, Professor, Chair of Hospital Therapy №1 №1
Trubetskaya ul. 8,Moscow, 119991
A. O. Yusupova
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Alfiya O. Yusupova - MD, PhD, Associate Professor, Chair of Hospital Therapy №1
Trubetskaya ul. 8,Moscow, 119991
S. M. Rykova
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Svetlana M. Rykova - MD, PhD, Associate Professor, Chair of Clinical Pharmacology and Pharmacotherapy, Institute of Professional Education
Trubetskaya ul. 8,Moscow, 119991
References
1. Kantrowitz A. Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. Surgery. 1953;34(4):678-87.
2. Soroff H.S., Birtwel W.C., Levine H.S., et al. Effect of counterpulsation upon myocardial oxygen consumption and heart work. Surg Forum Am Coll of Surg. 1962;13:174.
3. Birtwell W., Soroff H., Wall M. Assisted circulation: an improved method for counterpulsation. American Society for Artificial Internal Organs. 1962;8:35-42.
4. Cohen L.S., Multins C.B., Mitchell J.H. Sequenced external counterpulsation and inraaortic balloon pumping in cardiogenic schock. Am J Cardiol. 1973;38:635-66.
5. Soran O. The Role of Enhanced External Counterpulsation Therapy in the Management of Coronary Artery Disease. In: Piscione F., ed. Angina Pectoris. Rijeka: InTech; 2011.
6. Kern M.J., Aguirre F.V., Tatineni S., et al. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coil Cardiol. 1993;21:359-68.
7. Vozzi F., Bianchi F., Ahluwalia A., Domenici C. Hydrostatic pressure and shear stress affect endothelin1 and nitric oxide release by endothelial cells in bioreactors. Biotechnol J. 2014;9(1):146-54.
8. Yamazaki Y., Kondo Y., Kamiyama Y. Estimation of shear-stress-induced endothelial nitric oxide production from flow-mediated dilation. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:4521-4.
9. Kuchan M.J., Frangos J.A. Shear stress regulates endothelin-1 release via protein kinase C and Cgmp in cultured endothelial cells. Am J Physiol. 1993;264:H150-6.
10. Shakouri S.K., Razavi Z., Eslamian F., et al. Effect of Enhanced External Counterpulsation and Cardiac Rehabilitation on Quality of Life, Plasma Nitric Oxide, Endothelin 1 and High Sensitive CRP in Patients With Coronary Artery Disease: A Pilot Study. Ann Rehabil Med. 2015;39(2):191-8.
11. Barsness G.W. Enhanced external counterpulsation in unrevasculariz-able patients. Curr Interv Cardiol Rep. 2001;3:37-43.
12. Akhtar M., Wu G.F., Du Z.M., et al. Effect of external counterpulsation on plasma nitric oxide and endothelin1 levels. Am J Cardiol. 2006;98(1):28-30.
13. Beck D.T., Martin J.S., Casey D.P., et al. Enhanced external counterpulsation improves endothelial function and exercise capacity in patients with ischaemic left ventricular dysfunction. Clin Exp Pharmacol Physiol. 2014;41(9):628-36.
14. Xiong Y., Ren Y.F., Xu J., et al. Enhanced external counterpulsation inhibits endothelial apoptosis via modulation of BIRC2 and Apaf-1 genes in porcine hypercholesterolemia. Int J Cardiol. 2014;171(2): 161-8.
15. Luo C., Liu D., Wu G. Effect of enhanced external counterpulsation on coronary slow flow and its relation with endothelial function and inflammation: a mid-term follow-up study. Cardiology. 2012;122(4):260-8.
16. Lawson W.E., Hui J.C.K., Lu L., et al. Beneficial effects of EECP on the renin-angiotension system in patients with coronary artery disease (abstr). Eur Heart J. 2001;22 Suppl:538.
17. Kersten J.R., Pagel P.S., Chilian W.M., Warltier D.C. Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc Res. 1999;43:44-57.
18. Cai D., Wu R., Shao Y. Experimental study of the effect of external counterpulsation on blood circulation in the lower extremities. Clin Invest Med. 2000;23:239-47.
19. Resnick N., Collins T., Atkinson W., et al. Platelet derived growth factor B chain promoter contains a cis-acting shear-stress-responsive element. Proc Nati Acad Sci USA. 1993;90:4591-5.
20. Jacobey J.A., Tailor W.J., Smith G.P., et al. A new therapeutic approach to acute coronary occlusion. Am J Cardiol. 1963;11 (2):21 S-227.
21. Masuda D., Nohara K., Kataoka K., et al. Enhanced external counterpulsation promotes angiogenesis factors in patients with chronic stable angina. Circulation. 2001;104:II445.
22. Hood J.D., Meininger C. J., Ziche M., Granger H.J. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998;274:H1054-H1058.
23. Luo J.Y., Wu G.F., Xiong Y., et al. Enhanced external counterpulsation promotes growth cytokines-mediated myocardial angiogenesis in a porcine model of hypercholesterolemia. Chin Med J (Engl). 2009;122(10):1188-94.
24. Ku D.D., Zaieski J.K., Liu S., Brock T.A. Vascular endothelial growth factor induces EDRF'-dependent relaxation in coronary arteries. Am J Physiol. 1993;265:H586-92.
25. Luo C., Liu D., Du Z., et al. Short-term effects of enhanced external counterpulsation on transthoracic coronary flow velocity and reserve in patients with coronary slow flow. Int J Cardiol. 2012;154(1): 84-5.
26. Buschmann E.E., Utz W., Pagonas N., et al. Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial). Eur J Clin Invest. 2009;39(10): 866-75.
27. Masuda D., Nohara R., Hirai T., et al. Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography. Eur Heart J. 2001;22(16):1451-8.
28. Banas J., Brilla A., Levine H. Evaluation of external counterpulsation for the treatment of angina pectoris. Am Heart J. 1973;31:118.
29. Arora R. R., Chou T. M., Jain D. et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exerciseinduced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:1833-40.
30. Arora R.R., Chou T.M., Jain D., et al. Effects of enhanced external counterpulsation on health-related quality of life continue 12 months after treatment: a substudy of the multicenter study of enhanced external counterpulsation. J Investig Med. 2002;50:25-32.
31. Lawson W.E., Hui J.C., Barsness G.W. Effectiveness of enhanced external counterpulsation in patients with left main disease and angina. Clin Cardiol. 2004;27(8):459-63.
32. Michaels A.D., Linnemeier G., Soran O. Two-year outcomes after enhanced external counter pulsation for stable angina pectoris (from the123 International EECP Patient Registry [IEPR]). The American Journal of Cardiology. 2004;93(4):461-4.
33. Tarpgaard Jorgensen M., Gerdes C., May O. Prinzmetal's variant angina is effectively treated with enhanced external counter pulsation. Acta Cardiol. 2010;65(2):265-7.
34. Bagger J.P., Hall R.J., Koutroulis G., Nihoyannopoulos P. Effect of enhanced external counter pulsation on dobutamine-induced left ventricular wall motion abnormalities in severe chronic angina pectoris. Am J Cardiol. 2004;93(4):465-7.
35. Sinvhal R.M., Gowda R.M., Khan I.A. Enhanced external counter pulsation for refractory angina pectoris. Heart. 2003;89:830-3.
36. Medicare now provides limited EECP (enhanced external counterpulsation) coverage. Patient Acc. 1999;22(8):1-3.
37. Zheng Z.S. External counterpulsation in the treatment of 56 cases of acute myocardial infarction. Zhonghua Yi Xue Za Zhi. 1986;66(7):398-400. Chinese.
38. Maksimov A.I., Ryabov V.V., Markov V.A. The effect of increased external counterpulsation on hemodynamics and clinical course in acute myocardial infarction. Sibirskij Medicinskij Zhurnal. 2011;26(2):94-9. (In Russ.) [Максимов А.И., Рябов В.В., Марков В.А. Влияние усиленной наружной контрпульсации на гемодинамику и клиническое течение при остром инфаркте миокарда. Сибирский Медицинский Журнал. 2011;26(2): 94-9].
39. Strobeck J.E. Enhanced external counterpulsation in congestive heart failure: possibly the most potent inodilator to date. Congest Heart Fail. 2002;8(4):201-3.
40. Lawson W.E., Kennard E.D., Holubkov R., et al. Benefit and safety of enhanced external counterpulsation in treating coronary artery disease patients with a history of congestive heart failure. Cardiology. 2001;96:78-84.
41. Lawson W.E., Kennard E.D., Holubkov R., et al. What factors predict congestive heart failure during treatment of angina in patients with enhanced external counterpulsation. J Card Fail. 2002;7(suppl 2):48-175.
42. Lawson W.E., Pandey K., Hui J.C.K., et al. Benefit of enhanced external counterpulsation in coronary patients with left ventricular dysfunction: cardiac or peripheral effect? J Card Fail. 2002;8:S41-S146.
43. Soran O. A New Treatment Modality in Heart Failure: Enhanced External Counterpulsation (EECP). Cardiology in Review. 2004;12(1):15-20.
44. Gorcsan J. III, Crawford L., Soran O.Z., et al. Improvement in left ventricular performance by enhanced external counterpulsation in patients with heart failure. J Am Coll Cardiol. 2000;35:901-5.
45. Melin M., Montelius A., RydОn L. Effects of enhanced external counterpulsation on skeletal muscle gene expression in patients with severe heart failure. Clin Physiol Funct Imaging. 2016 Oct 26.
46. Rampengan S.H., Prihartono J., Siagian M., Immanuel S. The Effect of Enhanced External Counterpulsation Therapy and Improvement of Functional Capacity in Chronic Heart Failure patients: a Randomized Clinical Trial. Acta Med Indones. 2015;47(4):275-82.
47. Tecson K.M., Silver M.A., Brune S.D., et al. Impact of Enhanced External Counterpulsation on Heart Failure Rehospitalization in Patients With Ischemic Cardiomyopathy. Am J Cardiol. 2016;117(6):901-5.
48. KozdağG., Işeri P., GЪkНe G., et al. Treatment with enhanced external counterpulsation improves cognitive functions in chronic heart failure patients. Turk Kardiyol Dern Ars. 2013;41(5):418-28.
49. 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol. 2014;64(18):1929-49.
50. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J. 2013; 34: 2949-3003.
51. Diagnosis and treatment of stable angina pectoris. Russian recommendations. Kardiovaskuljarnaja Terapija i Profilaktika. 2008;7(6) suppl 4:1-24. (In Russ.) [Диагностика и лечение стабильной стенокардии. Российские рекомендации. Кардиоваскулярная Терапия и Профилактика. 2008; 7(6) Приложение 4: 1-24].
52. Dockery F., Rajkumar C., Bulpitt C.J., et al. Enhanced External Counterpulsation (EECP) does not alter arterial stiffness in patients with angina. Clinical Cardiology. 2004;27:689-92.
53. Casey D.P., Beck D.T., Nichols W.W., et al, Effects of enhanced external counterpulsation on arterial stiffness and myocardial oxygen demand in patients with chronic angina pectoris. Am J Cardiol. 2011;107(10):1466-72.
54. Xiong L., Lin W., Han J., et al. A retrospective pilot study of correlation of cerebral augmentation effects of external counterpulsation with functional outcome after acute ischaemic stroke. BMJ Open. 2015;5(9):e009233.
55. Werner D., Michalk F., Harazny J., et al. Accelerated reperfusion of poorly perfused retinal areas in central retinal artery occlusion and branch retinal artery occlusion after a short treatment with enhanced external counterpulsation. Retina. 2004;24(4):541-7.
56. Thakkar B.V., Hirsch A.T., Satran D., et al. The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial disease. Vasc Med. 2010;15(1):15-20.
57. Froschermaier S.E., Werner D., Leike S., et al. Enhanced external counterpulsation as a new treatment modality for patients with erectile dysfunction. Urol Int. 1998;61(3):168-71.
58. Raza A., Steinberg K., Tartaglia J., et al. Enhanced External Counterpulsation Therapy: Past, Present, and Future. Cardiol Rev. 2017;25(2):59-67.
Review
For citations:
Mamieva Z.A., Lishuta A.S., Belenkov Yu.N., Privalova E.V., Yusupova A.O., Rykova S.M. POSSIBILITIES OF ENHANCED EXTERNAL COUNTERPULSATION USING IN CLINICAL PRACTICE. Rational Pharmacotherapy in Cardiology. 2017;13(2):238-247. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-2-238-247
Views: 1806
Email this article 